Latest Interviews - Finance News Network

14 July 2025 - Progress in cancer and autoimmune disease treatment

14 July 2025 - Gold and silver both shine as trusted stores of wealth, but choosing between them depends on a few factors. Here's 5 things to consider when buying gold or silver.

01 July 2025 - Opportunities Across Sectors: Cancer Treatment, Critical Minerals, Natural Gas, Materials - Live ASX Company Webinar

27 June 2025 - A look at The Perth Mint's services and investment offerings, from bullion to ASX-listed products.

23 June 2025 - Large-cap quality, downside protection and shareholder returns

17 June 2025 - How Bob Sahota turned a defensive credit philosophy into one of Australia's most respected private debt funds.

13 June 2025 - Opportunities Across Sectors: Cybersecurity, Copper, Life Sciences, and Platinum Group Metals

03 June 2025 - How Mirrabooka manages ris, navigates volatility and uncovers value.

02 June 2025 - Tariff shocks, central bank inertia, defensive positioning.

27 May 2025 - The structure and portfolio advantages of investing in LICs.

26 May 2025 - Strong results in soft tissue sarcoma have capped off a busy quarter of immunotherapy progress

20 May 2025 - Navigating market headwinds with defensive tilt in 2Q25

13 May 2025 - Mission-critical communications with global expansion potential.

13 May 2025 - Cameron Cormack, Senior Portfolio Manager at VanEck, on ETF strategy and market outlook

12 May 2025 - Phil Smith, a Director at AL Capital, discusses the company's strategy and focus on capital protection.

12 May 2025 - Chairman James Walker discusses funding, contracts, and commercial momentum for 2025.

23 Apr 2025 - The road to commercialisation: Overcoming funding and regulatory hurdles in battery storage

21 Apr 2025 - Navigating the FDA Process and Clinical Trial Hurdles

16 Apr 2025 - Managing Director Jarrad Haynes shares how the firm is navigating risk, scaling development, and positioning for long-term growth.

09 Apr 2025 - Martin Stein discusses the supply chain, environmental, and ethical challenges of lithium-ion batteries and the benefits of Altech's alternative

07 Apr 2025 - The Final Steps in Drug Development and Market Access

02 Apr 2025 - Mike Huang on Glow's vision for full-spectrum women's health—and what comes next

26 Mar 2025 - The pros and cons of lithium and CERENERGY grid storage batteries

19 Mar 2025 - Michael Fazzini, Sales and Distribution Executive at Capital Prudential, discusses the company's strategy.

17 Mar 2025 - LAG-3 and the Role of Immune Checkpoints in Cancer Treatment

12 Mar 2025 - The demand for grid storage batteries in Europe

12 Mar 2025 - The launch of Sofdra and what's next for Botanix

12 Mar 2025 - Sofdra's rollout and the path to $100m revenue

11 Mar 2025 - Delivering predictable income streams through disicplined development

10 Mar 2025 - Addressing Chronic Conditions with Targeted Treatments

10 Mar 2025 - CEO Marc Voigt on Clinical Trials, Regulatory Milestones, and Market Growth

07 Mar 2025 - Markets, valuations, and volatility: What investors need to know

04 Mar 2025 - Opportunities for fixed-rate bond investors

03 Mar 2025 - Addressing Unmet Needs in Cancer Care

24 Feb 2025 - Immuno-oncology's Expanding Role in Cancer Treatment

14 Feb 2025 - Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events.

07 Feb 2025 - Capital Prudential's Sam Moore on unlocking property development opportunities.

05 Feb 2025 - CEO Andrew Terry discusses long-range wi-fi, semiconductor challenges, and the future of IoT connectivity.

17 Jan 2025 - Dr Shane Oliver, Head of Investment Strategy & Chief Economist at AMP, discusses developments in investment markets over the past week, economic activity trackers, major global economic events and Australian economic events.

16 Jan 2025 - Off the Chain Capital's CIO Brian Estes discusses Bitcoin's ethical implications, investment metrics, and future outlook.

13 Dec 2024 - Shaw and Partners Chief Investment Officer Martin Crabbe outlines a four-part investment strategy, focusing on growth, financial conditions, central bank policy and valuation. He notes that valuations remain high. He advises investors to adopt an active strategy, selecting individual growth-oriented stocks instead of relying on index funds.

11 Dec 2024 - INOVIQ's recent validation study of its EXO-OC test revealed it can detect stage one ovarian cancer with 96% specificity and more than 90% sensitivity, a promising advance for early detection.

07 Dec 2024 - Mount Hope Mining is preparing for a 9 December ASX listing, focusing on copper and gold exploration in the Cobar Basin, with five high-priority targets and a strategy based on recent geological insights.

26 Nov 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.

18 Nov 2024 - Empire Energy Group Limited (ASX:EEG) has commenced drilling for its Carpentaria Pilot Project after receiving environmental clearance. The initiative aims to deliver much-needed gas to the Northern Territory and east coast markets, supported by local and federal government strategies.

12 Nov 2024 - Dr Chris Burns, the CEO of NOVONIX Limited (ASX:NVX), shares details on a significant supply agreement with Stellantis for synthetic graphite, a milestone for the North American battery market.

12 November 2024 - The inaugural Semiconductor Australia conference was held on Thursday 24 October at Deloitte, Quay Quarter Tower, Sydney.

06 Nov 2024 - Paul Sanger interviewed Damian Spring, CEO of Santana Minerals Limited (ASX:SMI), to discuss the Bendigo gold project, which has recently been designated as a fast-track project.

05 Nov 2024 - Paul Sanger interviews Anthony Noble, CEO of The Calmer Co (ASX:CCO), a leader in sustainable kava production. The Calmer Co aims to become the world's dominant kava company by promoting kava's calming and health benefits while improving the livelihoods of farmers in Fiji through fair pricing and a transparent supply chain.

28 Oct 2024 - Australia's Chief Scientist, Dr Cathy Foley, AO PSM, presents at the Semiconductor Australia 2024 conference. She highlights Australia's strengths in tech development and outlines a vision for a sustainable economy led by innovation.

28 Oct 2024 - Jonathan Belz, CEO and Co-Founder of BFA Global Investors, presents at the Semiconductor Australia 2024 conference. Citing examples like Nvidia's rapid market cap increase, Belz discusses how AI, 5G, and data centres are shaping a new era for the sector.